Truist Financial Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price target hoisted by Truist Financial from $640.00 to $666.00 in a research report released on Friday,Benzinga reports. Truist Financial currently has a buy rating on the medical equipment provider’s stock.

Several other research analysts have also recently issued reports on the stock. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Trading Down 4.0 %

Shares of ISRG stock opened at $584.05 on Friday. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a fifty day simple moving average of $546.03 and a two-hundred day simple moving average of $503.38. The stock has a market capitalization of $208.03 billion, a price-to-earnings ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 42,475 shares of company stock valued at $22,070,807 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth about $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.